High Throughput News and Research

RSS

Arabica coffee's genetic legacy unveiled

The key to growing coffee plants that can better resist climate change in the decades to come may lie in the ancient past.

15 Apr 2024

Metrion Biosciences enhances High Throughput Screening services with access to Enamine compound libraries

...

From Metrion Biosciences Limited 11 Apr 2024

Innovative approach to disrupt misfolding of tau proteins in neurodegenerative diseases

A spectrum of neurodegenerative diseases, including frontotemporal dementia (FTD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are due to the accumulation of abnormal, misfolded tau proteins in the brain.

3 Apr 2024

AI-powered method predicts protein dynamics to accelerate drug discovery

Understanding the structure of proteins is critical for demystifying their functions and developing drugs that target them.

27 Mar 2024

As a new Core Lab under the Million Microbiomes from Humans Project, MGI empowers INRAE MetaGenoPolis in “Le microbiote français - Le French Gut”project to Propel Metagenomics Research

MGI, a company committed to building core tools and technology to lead life science, announced today a collaboration agreement with MetaGenoPolis, a unit within the renowned National Research Institute for Agriculture, Food and the Environment (INRAE) in France, following MetaGenoPolis' selection as a core lab under the Million Microbiomes from Humans Project (MMHP).

From MGI 6 Mar 2024

MGI Enters Strategic Partnership with Prepaire Labs to Advance Drug Discovery and Precision Medicine

MGI, a company committed to building core tools and technology to lead life science, today announced its collaboration with Prepaire Labs at MEDLAB Middle East 2024 to further empower precision medicine.

From MGI 6 Mar 2024

MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies

MGI Tech, a company committed to building core tools and technology to lead life science, today proudly announced a milestone collaboration with Eurofins Genomics Europe Genotyping A/S (“Eurofins Genomics”), which has placed a corporate order of the revolutionary DNBSEQ-T20×2 (“T20”) ultra-high throughput sequencer, along with the genomics data center ZTRON Appliance and a range of MGI’s state-of-the-art laboratory automation products and systems.

From MGI 6 Mar 2024

Ultima announces UG 100™ and reveals disruptive cost and accuracy profile to enable the era of the $100 genome and beyond

Today, the Company is also introducing ppmSeqTM, a disruptive new mode for extreme raw read accuracy in calling single nucleotide variants (SNVs). ppmSeqTM is a new proprietary feature enabled by Ultima’s unique approach that dramatically improves the raw read accuracy of calling SNVs by removing sample errors introduced upstream of the sequencing workflow.

From Ultima Genomics, Inc. 26 Feb 2024

INTEGRA's innovative modules simplify magnetic bead purification workflows

INTEGRA Biosciences is excited to announce the launch of its MAG and HEATMAG modules for efficient, automated magnetic bead purification.

From INTEGRA Biosciences 22 Feb 2024

Cellectricon’s expertise in pain research recognized by second EU research grant

BonePainIII project will support an early-stage researcher in quest for novel mechanistic insight and potential therapeutic targets.

From Cellectricon 19 Feb 2024

CDC releases new syphilis testing guidelines to combat rising cases

The CDC's new guidelines in the Morbidity and Mortality Weekly Report outline comprehensive testing protocols for syphilis diagnosis, emphasizing the combined use of nontreponemal and treponemal tests to improve detection and management of the disease in the U.S.

11 Feb 2024

ELRIG UK announces Steve Bates and Dr Anderson Ryan as keynote speakers at Research and Innovation 2024

The European Laboratory Research & Innovation Group (ELRIG) UK today announced the keynote speakers for its upcoming Research and Innovation conference taking place at the University of Manchester from 20–21 March.

From ELRIG (UK) Ltd. 8 Feb 2024

New, automated shake and fire platforms from Copley cut the burden of MDI and nasal drug product testing.

The latest generation of Vertus® automated shake and fire platforms from Copley Scientific make it easy and intuitive to integrate automation into a wide range of drug product testing workflows to boost productivity, drive down test variability, and simplify training.

From Copley Scientific Limited 17 Jan 2024

Patient-specific muscle models pave way for personalized neuromuscular therapies

Scientists have so far identified around 800 different neuromuscular diseases. These conditions are caused by problems in the way muscle cells, motor neurons and peripheral cells interact.

19 Dec 2023

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

Amidst a backdrop of industry-wide hurdles like inflation, talent scarcities, and stringent regulatory landscapes, Nona Biosciences is showing great promise as an emerging global leader in biotechnology.

From Nona BioSciences 19 Dec 2023

Investigating IDO1 and PDL1: Key immune checkpoints in cutaneous leishmaniasis research

In this Interview News Med talks to Dr. Nidhi Dey about immune checkpoints IDO1 and PDL1 and how they relate to cutaneous leishmaniasis research.

From TissueGnostics 5 Dec 2023

Unveiling a new cardiac myosin inhibitor through AI-driven virtual screening

Discovery of a novel cardiac-specific myosin modulator.

28 Nov 2023

Ingenza and Phibro Ethanol accelerate the green fuel transition

Ingenza and Phibro Ethanol – a division of Phibro Animal Health Corporation – have joined forces to engineer a novel yeast strain that will increase yield in the commercial production of bioethanol under both challenging and conventional environmental conditions, further driving the switch to clean biofuels.

From Ingenza Ltd 24 Nov 2023

Machine learning uncovers potent immunomodulators for vaccines and immunotherapy

Small molecules called immunomodulators can help create more effective vaccines and stronger immunotherapies to treat cancer.

17 Nov 2023

Research investigates a novel strategy for inhibiting the spread of Vibrio cholerae

Karl Klose, director of The South Texas Center for Emerging Infectious Diseases (STCEID) and the Robert J. Kleberg, Jr. and Helen C. Kleberg College of Sciences Endowed Professor, coauthored a research article with Cameron Lloyd '23, a UTSA doctoral student who graduated in August with a Ph.D. in molecular microbiology and immunology under the guidance of Klose.

7 Nov 2023

High Throughput News and Research

Arabica coffee's genetic legacy unveiled

Metrion Biosciences enhances High Throughput Screening services with access to Enamine compound libraries

Innovative approach to disrupt misfolding of tau proteins in neurodegenerative diseases

AI-powered method predicts protein dynamics to accelerate drug discovery

As a new Core Lab under the Million Microbiomes from Humans Project, MGI empowers INRAE MetaGenoPolis in “Le microbiote français - Le French Gut”project to Propel Metagenomics Research

MGI Enters Strategic Partnership with Prepaire Labs to Advance Drug Discovery and Precision Medicine

MGI Tech and Eurofins Genomics Partner to Elevate Precision Health with Revolutionary DNBSEQ-T20×2 Sequencer and Related Technologies

Ultima announces UG 100™ and reveals disruptive cost and accuracy profile to enable the era of the $100 genome and beyond

INTEGRA's innovative modules simplify magnetic bead purification workflows

Cellectricon’s expertise in pain research recognized by second EU research grant

CDC releases new syphilis testing guidelines to combat rising cases

ELRIG UK announces Steve Bates and Dr Anderson Ryan as keynote speakers at Research and Innovation 2024

New, automated shake and fire platforms from Copley cut the burden of MDI and nasal drug product testing.

Patient-specific muscle models pave way for personalized neuromuscular therapies

Bridging ideas to IND: Nona Biosciences' year of impact in biotechnology

Investigating IDO1 and PDL1: Key immune checkpoints in cutaneous leishmaniasis research

Unveiling a new cardiac myosin inhibitor through AI-driven virtual screening

Ingenza and Phibro Ethanol accelerate the green fuel transition

Machine learning uncovers potent immunomodulators for vaccines and immunotherapy

Research investigates a novel strategy for inhibiting the spread of Vibrio cholerae

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News